Purposefully priced?
Gilead did pay $11 billion to acquire Pharmasset and at one point was facing a $2.5 billion patent infringement ruling (later overturned) for that same drug.
AbbVie’s a new entrant which can treat certain strains at at about a third the cost.
Damn that Late Stage Capitalism developing a miracle cure for Hep C which is painless and effective.